Insider / JOHNSON & JOHNSON
Doudna Jennifer A
Director at JOHNSON & JOHNSON
- Company
- JOHNSON & JOHNSON
- First filing on record
- November 13, 2025
- Latest trade on record
- September 1, 2026
- SEC filings
- EDGAR ↗
Doudna Jennifer A, Director at JOHNSON & JOHNSON, has disclosed 7 transactions in TEM, JNJ since November 13, 2025: 0 purchases (0 open-market buys) and 5 sales, worth about $455K at the reported prices. The latest was filed September 3, 2026, 2 days after the trade; 1 filing was late against the 2-business-day Form 4 deadline.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months Doudna Jennifer A made no purchases and 5 sales worth $455K, plus 2 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Doudna Jennifer A has traded 1 stock on record; the largest by dollars is TEM.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
1 of 7 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| S | Open-market sale | 5 | 7,201 | $455K |
| A | Grant or award | 2 | 6,888 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 5 | 0 | 3 · $267K |
| 2025 | 2 | 0 | 2 · $189K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| TEM | Sell S | September 1, 2026 | September 3, 2026 | 2d | 676 | $66 | $44K | 10b5-1 plan | Form 4 ↗ | |
| TEM | Sell S | June 25, 2026 | June 29, 2026 | 4d | 2,673 | $55 | $147K | 10b5-1 plan | Form 4 ↗ | |
| TEM | Other A | May 21, 2026 | May 26, 2026 | 5d | 5,913 | — | — | late | Form 4 ↗ | |
| JNJ | Other A | April 23, 2026 | April 27, 2026 | 4d | 975 | — | — | derivative | Form 4 ↗ | |
| TEM | Sell S | January 2, 2026 | January 6, 2026 | 4d | 1,250 | $60 | $75K | 10b5-1 plan | Form 4 ↗ | |
| TEM | Sell S | December 1, 2025 | December 3, 2025 | 2d | 676 | $76 | $51K | 10b5-1 plan | Form 4 ↗ | |
| TEM | Sell S | November 11, 2025 | November 13, 2025 | 2d | 1,926 | $71 | $138K | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| September 3, 2026 | Form 4 | 0001739090-26-000012 | 1 | published | EDGAR ↗ |
| June 29, 2026 | Form 4 | 0001739090-26-000006 | 1 | published | EDGAR ↗ |
| May 26, 2026 | Form 4 | 0001739090-26-000004 | 1 | published | EDGAR ↗ |
| April 27, 2026 | Form 4 | 0000200406-26-000094 | 1 | published | EDGAR ↗ |
| January 6, 2026 | Form 4 | 0001739090-26-000002 | 1 | published | EDGAR ↗ |
| December 3, 2025 | Form 4 | 0001739090-25-000005 | 1 | published | EDGAR ↗ |
| November 13, 2025 | Form 4 | 0001739090-25-000003 | 1 | published | EDGAR ↗ |
Other insiders at JOHNSON & JOHNSON
- LEFKOFSKY ERIC P CEO and Chairman 144 rows
- Fukushima Ryan Chief Operating Officer 40 rows
- Wolk Joseph J Exec VP, CFO 34 rows
- Schmid Timothy EVP, WW Chair, MedTech 31 rows
- Broadhurst Vanessa EVP, Global Corp Affairs 25 rows
- Swanson James D. EVP, CIO 24 rows
- Wengel Kathryn E EVP, Chief TO and Risk Officer 24 rows
- Duato Joaquin CEO and Chairman of the Board 23 rows
- Taubert Jennifer L Director 23 rows
- Forminard Elizabeth EVP, Chief Legal Officer 22 rows
Everyone on file, with contracts and lobbying under the company's name: JOHNSON & JOHNSON.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Rule 10b5-1 trading plans The plan must be set up when the insider has no important non-public information.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 7 | 7 | November 13, 2025 | September 3, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.